We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


  Silver Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App

Erba Mannheim Launches Second Generation SARS-CoV-2 RT-PCR Assay with Room Temperature Storage

By LabMedica International staff writers
Posted on 22 Jan 2021
Print article
Image: ErbaMDx SARS-CoV-2 RT-PCR Kit (Photo courtesy of Erba Mannheim)
Image: ErbaMDx SARS-CoV-2 RT-PCR Kit (Photo courtesy of Erba Mannheim)
Erba Mannheim (London, UK) has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for the detection of SARS-CoV-2.

The ErbaMDx SARS-COV-2 RT-PCR kit is a molecular diagnostic test that aids the detection and diagnosis of COVID-19 infections and is based on latest nucleic acid amplification technologies. It is a real-time reverse transcriptase PCR test that has been developed utilizing universally trusted priming sites with updated primer sequences to maximize long term performance.

To overcome challenges in older COVID-19 molecular tests, Erba's Cambridge (UK)-based development team has carefully engineered the new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation. The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximize long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva. The test has been validated for use with commonly available extraction kits and commonly available real time PCR analyzers. The CE-marked kit will be available through Erba's global distribution network.

"We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions," said Nikhil Vazirani, MD of Erba. "The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination."

Related Links:
Erba Mannheim

Gold Supplier
Virus Transport and Preservation Medium – Inactivated
Virus Transport and Preservation Medium – Inactivated
Laboratory Automation Solution
COVID-19 Anitibody Test
Gold Supplier
Nucleic Acid Extractor (Magnetic Bead Method)

Print article


Molecular Diagnostics

view channel
Image: Histopathologic image from a patient with Li Fraumeni syndrome showing accumulation of mutant TP53 in tumoral cells (Photo courtesy of Thierry Soussi, PhD).

Clinical Germline Testing Evaluated for Pediatric Cancer Patients

Pediatric cancer is rare, with fewer than 10,000 solid tumors diagnosed in children annually in the USA. Previous studies interrogating germline predisposition broadly across pediatric cancer types have... Read more


view channel

Mindray and Tencent AI Lab to Jointly Develop AI Products for Blood Disease Screening and In Vitro Diagnosis

Shenzhen Mindray Biomedical Electronics Co., Ltd. (Shenzhen, China) has signed an AI cooperation framework agreement with Tencent AI Lab (Shenzhen, China) to jointly develop AI products for blood cell... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.